Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03484702
Title Trial to Determine the Efficacy and Safety of JCAR017 in Adult Subjects With Aggressive B-Cell Non-Hodgkin Lymphoma (TRANSCENDWORLD)
Acronym TRANSCENDWORLD
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ITA | GBR | FRA | FIN | ESP | DEU | CHE | BEL | AUT

Facility Status City State Zip Country Details
Local Institution - 101 Wien 1090 Austria Details
Local Institution - 351 Gent 9000 Belgium Details
Local Institution - 551 Helsinki 00029 Finland Details
Local Institution - 202 Lille 59037 France Details
Local Institution - 203 Paris Cedex 10 75475 France Details
Local Institution - 201 Pierre Benite cedex 69495 France Details
Local Institution - 152 Dresden 01307 Germany Details
Local Institution - 155 Heidelberg 69120 Germany Details
Local Institution - 151 Köln 50937 Germany Details
Local Institution - 154 München 81377 Germany Details
Local Institution - 153 Ulm 89081 Germany Details
Local Institution - 402 Milan 20133 Italy Details
Local Institution - 401 Torino 10126 Italy Details
Local Institution - 601 Chuo-ku Tokyo 104-0045 Japan Details
Local Institution - 602 Minato-ku Tokyo 105-8470 Japan Details
Local Institution - 301 Rotterdam 3015 CE Netherlands Details
Local Institution - 451 Barcelona 08035 Spain Details
Local Institution - 251 Bern 3010 Switzerland Details
Local Institution - 502 Manchester Lancashire M20 4BX United Kingdom Details
Local Institution - 501 London WC1E 6BT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field